![Kathryn Haviland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 161 755 $ al 31/05/2026
Kathryn Haviland forma parte del consejo de Fulcrum Therapeutics, Inc. y es directora de operaciones de Blueprint Medicines Corp., miembro de la Asociación de Antiguos Alumnos de la Industria de la Salud de la Escuela de Negocios de Harvard y miembro del Consejo Ejecutivo de Biopharma. Anteriormente, la Sra. Haviland ocupó el cargo de Vicepresidenta de Enfermedades Raras en Idera Pharmaceuticals, Inc., Jefa de Desarrollo Comercial en Sarepta Therapeutics, Inc. y Directora Ejecutiva de Desarrollo Comercial en PTC Therapeutics, Inc. Se licenció en la Universidad de Wesleyan y obtuvo un MBA en la Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BICARA THERAPEUTICS INC. 0,01 % | 09/06/2026 | 7.437 ( 0,01 % ) | 161 755 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
AVALYN PHARMA INC -.--% | 30/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Presidente | 10/01/2022 |
| BICARA THERAPEUTICS INC. | Director/Miembro de la Junta | 21/09/2023 |
| AVALYN PHARMA INC. | Director/Miembro de la Junta | 01/03/2026 |
Harvard Business School Health Industry Alumni Association | Corporate Officer/Principal | - |
Biopharma Executive Council
 Biopharma Executive Council Miscellaneous Commercial ServicesCommercial Services Operates as biotech and pharmaceutical executive level membership council | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Director Ejecutivo | 01/01/2026 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | 01/12/2015 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2014 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Harvard Business School Health Industry Alumni Association | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Biopharma Executive Council
Biopharma Executive Council Miscellaneous Commercial ServicesCommercial Services Operates as biotech and pharmaceutical executive level membership council | Commercial Services |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
